prostate-specific MAb (NIH)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameprostate-specific MAb (NIH)

Drug Alias Nameanti-PSA-OP monoclonal antibodies (NIH)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateDiagnostic agent (In vivo)

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNational Institutes Of Health

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational Institutes Of Health

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A